What is the difference between empiric and targeted antimicrobial therapy?

Empiric therapy is started before the causative organism is known, using broad-spectrum agents chosen to cover the most likely pathogens. Targeted therapy is the narrower treatment selected once cultures and sensitivities identify the organism, allowing the regimen to be de-escalated.

What is antibiotic stewardship?

Antibiotic stewardship is a coordinated programme to ensure antimicrobials are used only when needed and in the optimal agent, dose, route, and duration. Its goals are to improve patient outcomes while reducing antimicrobial resistance, toxicity, and other harms.

Antimicrobial Therapy and Antibiotic Stewardship

Antimicrobial therapy is the use of anti-infective drugs to treat bacterial, viral, fungal, and other infections, and it is central to the care of patients with sepsis and severe infection in intensive and emergency settings. Antibiotic stewardship is the coordinated effort to use these drugs wisely — the right agent, dose, route, and duration — to improve outcomes while limiting resistance and harm.

Definition

Antimicrobial therapy and antibiotic stewardship is the treatment of infection with anti-infective agents together with the systematic effort to optimize their selection, dosing, route, and duration so as to maximize benefit and minimize resistance, toxicity, and other harms.

Scope

The topic covers the place of antimicrobial therapy in critical and emergency care: the rationale for prompt, often empiric, treatment in sepsis; the principle of de-escalation as cultures return; the pharmacologic challenge of dosing antibiotics in unstable patients; and the goals and methods of stewardship. It is a reference and educational overview and does not provide dosing, agent-selection, or treatment recommendations for individual patients.

Core questions

Why is prompt empiric antimicrobial therapy emphasized in sepsis, and how is it later refined?
What makes antibiotic dosing in critically ill patients particularly difficult?
What are the aims and core interventions of an antimicrobial stewardship programme?

Key concepts

Empiric versus targeted (culture-directed) therapy
De-escalation and source control
Pharmacokinetic/pharmacodynamic dosing
Therapeutic drug monitoring of selected agents
Antimicrobial stewardship
Antimicrobial resistance
Sepsis recognition and timely treatment

Mechanisms

In suspected severe infection, therapy is often started empirically with broad-spectrum agents chosen to cover likely organisms, then narrowed (de-escalated) once cultures and sensitivities are available, alongside control of the infection source. Effectiveness depends on pharmacokinetic/pharmacodynamic relationships — for some drugs the time the concentration stays above a threshold matters, for others the peak concentration — and critical illness disturbs these relationships through altered volume of distribution and clearance, sometimes requiring adjusted dosing or therapeutic drug monitoring. Stewardship programmes apply these principles at a system level to align use with need and to slow resistance.

Clinical relevance

Antimicrobials are among the most frequently administered drugs in critical and emergency care, and their timing, preparation, and monitoring are part of routine nursing work in sepsis and severe infection. Awareness of empiric-then-targeted logic, of the difficulty of dosing in unstable patients, and of stewardship goals supports accurate administration and observation. This entry describes how the therapy is organized and monitored and is not a source of dosing or individualized treatment advice.

Evidence & guidelines

The topic draws on the Surviving Sepsis Campaign guidelines and the Sepsis-3 consensus definitions for the treatment of sepsis, the Infectious Diseases Society of America / Society for Healthcare Epidemiology of America stewardship guidelines, and reviews of antibiotic dosing in critical illness. These are reference sources describing how care is generally organized rather than directives for an individual patient.

History

The expansion of antibiotics transformed the treatment of infection, but rising resistance and recognition of avoidable harm prompted the development of stewardship as a formal discipline. In parallel, the sepsis field moved toward earlier recognition and treatment, codified in successive Surviving Sepsis Campaign documents and the Sepsis-3 definitions, while pharmacologists drew attention to the special problem of dosing antibiotics in critically ill patients.

Debates

How should speed of antibiotics be balanced against stewardship?: Sepsis guidance emphasizes very early antimicrobial therapy to reduce mortality, while stewardship cautions against unnecessary broad-spectrum use; reconciling rapid empiric treatment with prompt de-escalation is an ongoing tension.
Do critically ill patients need individualized antibiotic dosing?: Altered pharmacokinetics in critical illness can cause standard regimens to under- or over-expose patients, prompting proposals for dose individualization and therapeutic drug monitoring, though how widely this is needed remains under study.

Seminal works

evans-2021
barlam-2016
roberts-2014

Frequently asked questions

What is the difference between empiric and targeted antimicrobial therapy?: Empiric therapy is started before the causative organism is known, using broad-spectrum agents chosen to cover the most likely pathogens. Targeted therapy is the narrower treatment selected once cultures and sensitivities identify the organism, allowing the regimen to be de-escalated.
What is antibiotic stewardship?: Antibiotic stewardship is a coordinated programme to ensure antimicrobials are used only when needed and in the optimal agent, dose, route, and duration. Its goals are to improve patient outcomes while reducing antimicrobial resistance, toxicity, and other harms.